Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Transplantation in Bone Marrow Failure or Inherited Diseases
NCT00003662Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Aug 1998
- Primary completion
- Jan 2001
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, open-label trial of umbilical cord blood in aplastic anemia, myelodysplastic syndrome (MDS), inborn error of metabolism (IEM) and 1 more (3 cohorts), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoints: Rate of Durable Engraftment, Incidence and Severity of Acute and Chronic Graft-Versus-Host Disease and 3 more. Started Aug 1998; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
aplastic anemiamyelodysplastic syndrome (MDS)inborn error of metabolism (IEM)Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT00003662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003662.